Serum albumin and blood haemoglobin: Do they have any cost-effective predictive value in assessing the functional outcome of acute ischaemic stroke in the present era?
Background: The available prognostic indicators of stroke at present are based on neurological findings. There are not enough cost-effective and feasible blood biomarkers in assessing functional outcomes in acute ischaemic stroke. Methods: In this prospective observational study (n = 223) predictive...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Journal of Clinical and Scientific Research |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jcsr.jcsr_240_22 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background:
The available prognostic indicators of stroke at present are based on neurological findings. There are not enough cost-effective and feasible blood biomarkers in assessing functional outcomes in acute ischaemic stroke.
Methods:
In this prospective observational study (n = 223) predictive value of serum albumin and blood haemoglobin levels in assessing the functional outcome in subjects with acute ischaemic stroke was studied. The subjects were followed up for 3 months from the day of admission. The outcomes were assessed on day 1, day 7 and end of 3 months of the onset of acute ischaemic stroke using Modified Rankin Scale (MRS).
Results:
The mean serum albumin level was 2.8 ± 0.5 g/dL and haemoglobin level was 9.5 ± 1.9 g/dL in severe acute ischaemic stroke subjects. The 39.46% of acute ischaemic stroke subjects were having serum albumin of 2.9 ± 0.5 g/dL and Hb% of 9.8 ± 1.7 g/dL with MRS score of more than 3 with poor prognosis after 3 months of follow-up (P value < 0.05).
Conclusions:
The serum albumin and blood Hb levels are cost-effective and highly feasible blood biomarkers in assessing the prognosis in subjects with acute ischaemic stroke. |
|---|---|
| ISSN: | 2277-5706 2277-8357 |